International guidelines for the management and treatment of Morquio a syndrome

American Journal of Medical Genetics, Part A

Volumn 167, Issue 1, 2015, Pages 11-25

  Hendriksz, Christian J ^a   Berger, Kenneth I ^b   Giugliani, Roberto ^c   Harmatz, Paul ^d   Kampmann, Christoph ^e   Mackenzie, William G ^f   Raiman, Julian ^g   Villarreal, Martha Solano ^h   Savarirayan, Ravi ⁱ  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Medical Genetics Service/HCPA ^*  (Brazil)

^d CHILDREN S HOSPITAL OAKLAND   (United States)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

ⁱ MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Diagnosis; Disease management; Guidelines; Mucopolysaccharidosis IV; Symptom assessment

Indexed keywords

BRONCHODILATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELOSULFASE ALFA; FLUORIDE; INFLUENZA VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE;

ABDOMINAL DISEASE; ANESTHESIA; BODY GROWTH; CARDIOVASCULAR DISEASE; CLINICAL CLASSIFICATION; DENTAL PROCEDURE; DISEASE ASSOCIATION; DRUG EFFICACY; ENDURANCE; ENZYME REPLACEMENT; EYE DISEASE; EYE SURGERY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEARING AID; HEARING IMPAIRMENT; HEART VALVE REPLACEMENT; HUMAN; MORQUIO SYNDROME; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; ORTHOPEDIC SURGERY; PAIN; PATIENT CARE; PATIENT MONITORING; PERIOPERATIVE PERIOD; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL EXAMINATION; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SPINAL CORD DECOMPRESSION; STOMACH SURGERY; TOOTH DISEASE; TRACHEOSTOMY; TREATMENT DURATION; TREATMENT INDICATION; VACCINATION; COMPLICATION; INTERNATIONAL COOPERATION; MUCOPOLYSACCHARIDOSIS IV; RADIOGRAPHY;

IVA;

HUMANS; INTERNATIONALITY; MUCOPOLYSACCHARIDOSIS IV; PRACTICE GUIDELINES AS TOPIC;

EID: 84919625862     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36833     Document Type: Review

References (74)

1. Aaron DH, Jansen CW. 2003. Development of the Functional Dexterity Test (FDT): Construction, validity, reliability, and normative data. J Hand Ther 16:12-21.
2. Ahmedzai S, Balfour-Lynn IM, Bewick T, Buchdahl R, Coker RK, Cummin AR, Gradwell DP, Howard L, Innes JA, Johnson AO, Lim E, Lim WS, McKinlay KP, Partridge MR, Popplestone M, Pozniak A, Robson A, Shovlin CL, Shrikrishna D, Simonds A, Tait P, Thomas M. 2011. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 66:i1-i30.
3. Algahim MF, Almassi GH. 2013. Current and emerging management options for patients with Morquio A syndrome. Ther Clin Risk Manag 9:45-53.
4. American Thoracic Society. 2002. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111-117.
5. Ashworth JL, Biswas S, Wraith E, Lloyd IC. 2006. Mucopolysaccharidoses and the eye. Surv Ophthalmol 51:1-17.
6. Ashworth JL, Kruse FE, Bachmann B, Tormene AP, Suppiej A, Parini R, Guffon N. 2010. Ocular manifestations in the mucopolysaccharidoses-A review. Clin Experiment Ophthalmol 28:12-22.
7. Aslam R, van Bommel AC, Hendriksz CJ, Jester A. 2013. Subjective and objective assessment of hand function in mucopolysaccharidosis IVa patients. JIMD Rep 9:59-65.
8. Atinga M, Hamer AJ. 2008. Total knee replacements in a patient with the Morquio syndrome. J Bone Joint Surg Br 90:1631-1633.
9. Berger KI, Fagondes SC, Giugliani R, Hardy KA, Lee KS, McArdle C, Scarpa M, Tobin MJ, Ward SA, Rapoport DM. 2012. Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis 36:201-210.
10. Braunlin EA, Harmatz PR, Scarpa M, Furlanetto B, Kampmann C, Loehr JP, Ponder KP, Roberts WC, Rosenfeld HM, Giugliani R. 2011. Cardiac disease in patients with mucopolysaccharidosis: Presentation, diagnosis and management. J Inherit Metab Dis 34:1183-1197.
11. Bredenkamp JK, Smith ME, Dudley JP, Williams JC, Crumley RL, Crockett DM. 1992. Otolaryngologic manifestations of the mucopolysaccharidoses. Ann Otol Rhinol Laryngol 101:472-478.
12. Cahane M, Treister G, Abraham FA, Melamed S. 1990. Glaucoma in siblings with Morquio syndrome. Br J Ophthalmol 74:382-383.
13. Camelier MV, Burin MG, De Mari J, Vieira TA, Marasca G, Giugliani R. 2011. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples. Clin Chim Acta 412:1805-1808.
14. Couprie J, Denis P, Guffon N, Reynes N, Masset H, Beby F. 2010. Ocular manifestations in patients affected by Morquio syndrome (MPS IV). J Fr Ophtalmol 33:617-622.
15. Dalvie S, Skinner J, Vellodi A, Noorden MHH. 2001. Mobile thoracolumbar gibbus in Morquio type A: The cause of paraparesis and its management. J Pediatr Orthop B 10:328-330.
16. Dangel ME, Tsou BH. 1985. Retinal involvement in Morquio's syndrome (MPS IV). Ann Ophthalmol 17:349-354.
17. Davison JE, Kearney S, Horton J, Foster K, Peet AC, Hendriksz CJ. 2013. Intellectual and neurological functioning in Morquio syndrome (MPS IVa). J Inherit Metab Dis 36:323-328.
18. Dede O, Thacker MM, Rogers KJ, Oto M, Belthur MV, Baratela W, Mackenzie WG. 2013. Upper cervical fusion in children with Morquio syndrome: Intermediate to long-term results. J Bone Joint Surg Am 95:1228-1234.
19. Dhawale AA, Church C, Henley J, Holmes L, Jr., Thacker MM, Mackenzie WG, Miller F. 2013. Gait pattern and lower extremity alignment in children with Morquio syndrome. J Pediatr Orthop B 22:59-62.
20. Dhawale AA, Thacker MM, Belthur MV, Rogers K, Bober MB, Mackenzie WG. 2012. The lower extremity in Morquio syndrome. J Pediatr Orthop 32:534-540.
21. Fahnehjelm KT, Ashworth JL, Pitz S, Olsson M, Törnquist AL, Lindahl P, Summers CG. 2012. Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis. Acta Ophthalmol 90:595-602.
22. Fung EB, Johnson JA, Madden J, Kim T, Harmatz P. 2010. Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI. J Pediatr Rehabil Med 3:13-23.
23. Harmatz P, Ketteridge D, Giugliani R, Guffon N, Teles EL, Miranda MC, Yu ZF, Swiedler SJ, Hopwood JJ. 2005. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): Results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics 115:e681-e689.
24. Harmatz P, Giugliani R, Schwartz I, Guffon N, Teles EL, SáMiranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Yu ZF, Wittes J, Berger KI, Newman MS, Lowe AM, Kakkis E, Swiedler SJ. 2006. Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 148:533-539.
25. Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin SP, Parini R, Guffon N, Burton BK, Hendriksz CJ, Mitchell J, Martins A, Jones S, Guelbert N, Vellodi A, Hollak C, Slasor P, Decker C. 2013. The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab 109:54-61.
26. Hendriksz C, Vellodi A, Jones S, Takkele H, Lee S, Chesler S, Decker C. 2012. Long term outcomes of a phase 1/2, multicenter, open-label, dose-escalation study to evaluate the safety, tolerability, and efficacy of BMN 110 in patients with mucopolysaccharidosis IVA (Morquio A syndrome). Mol Genet Metab 105:S35.
27. Hendriksz CJ, Al-Jawad M, Berger KI, Hawley SM, Lawrence R, McArdle C, Summers CG, Wright E, Braunlin E. 2013a. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis 36:309-322.
28. Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S. 2013b. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab 110:54-64.
29. Hendriksz CJ. 2013c. Transition services for adolescents with lysosomal storage disorders. CML-Lysosomal Storage Diseases 11:69-76.
30. Hendriksz CJ, Burton B, Fleming TR, et al. 2014a. Efficacy and safety of enzyme replacement therapy with BMN 110 for Morquio A Syndrome (mucopolysaccharidosis IVA): A phase 3 randomised placebo-controlled study. J Inherit Metab Dis doi:10.1007/s10545-014-9715-6.
31. Hendriksz CJ, Lavery C, Coker M, KalkanUcar S, Jain M, Bell L, Lampe C. 2014b. Burden of disease in patients with Morquio A syndrome: Results from an international patient-reported outcomes survey. Orphanet J Rare Dis. 9:32.
32. Iwamoto M, Nawa Y, Maumenee IH, Young-Ramsaran J, Matalon R, Green WR. 1990. Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A). Graefes Arch Clin Exp Ophthalmol 228:342-349.
33. James A, Hendriksz CJ, Addison O. 2012. The oral health needs of children, adolescents and young adults affected by a mucopolysaccharide disorder. JIMD Rep 2:51-58.
34. Käsmann-Kellner B, Weindler J, Pfau B, Ruprecht KW. 1999. Ocular changes in mucopolysaccharidosis IV A (Morquio A syndrome) and long-term results of perforating keratoplasty. Ophthalmologica 213:200-205.
35. Kinirons MJ, Nelson J. 1990. Dental findings in mucopolysaccharidosis type IV A (Morquio's disease type A). Oral Surg Oral Med Oral Pathol 70:176-179.
36. Lachman RS, Burton B, Clarke LA, Hoffinger S, Ikegawa S, Jin D-K, Kano H, Kim O-H, Lampe C, Mendelsohn NJ, Shediac R, Tapaiboon P, White KK. 2014. Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): Under-recognized and challenging to diagnose. Skeletal Radiol 43:359-369.
37. Leslie T, Siddiqui MAR, Aitken DA, Kirkness CM, Lee WR, Fern AI. 2005. Morquio syndrome: Electron microscopic findings. Br J Ophthalmol 89:925-926.
38. Lipson SJ. 1977. Dysplasia of the odontoid process in Morquio's syndrome causing quadriparesis. J Bone Joint Surg Am 59:340-344.
39. Marshall WA, Tanner JM. 1969. Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303.
40. Marshall WA, Tanner JM. 1970. Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23.
41. Martins AM, Dualibi AP, Norato D, Takata ET, Santos ES, Valadares ER, Porta G, de Luca G, Moreira G, Pimentel H, Coelho J, Brum JM, Semionato Filho J, Kerstenetzky MS, Guimarães MR, Rojas MVM, Aranda PC, Pires RF, Faria RGC, Mota RMV, Matte U, Guedes ZC. 2009. Guidelines for the management of mucopolysaccharidosis type I. J Pediatr 155:S32-S46.
42. Mendelsohn NJ, Wood T, Olson RA, Temme R, Hale S, Zhang H, Read L, White KK. 2013. Spondyloepiphyseal dysplasias and bilateral legg-calve-perthes disease: Diagnostic considerations for mucopolysaccharidoses. JIMD Rep 11:125-132.
43. Montaño AM, Tomatsu S, Brusius A, Smith M, Orii T. 2008. Growth charts for patients affected with Morquio A disease. Am J Med Genet A 146A:1286-1295.
44. Montaño AM, Tomatsu S, Gottesman GS, Smith M, Orii T. 2007. International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30:165-174.
45. Morrone A, Tylee KL, Al-Sayed M, Brusius-Facchin AC, Caciotti A, Church HJ, Coll MJ, Davidson K, Fietz MJ, Gort L, Hegde M, Kubaski F, Lacerda L, Laranjeira F, Leistner-Segal S, Mooney S, Pajares S, Pollard L, Ribeiro I, Wang RY, Miller N. 2014. Molecular Testing of 163 Patients with Morquio A (Mucopolysaccharidosis IVA) Identifies 39 Novel GALNS Mutations. Mol Genet Metab 112:160-170.
46. Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A. 2006. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 8:465-473.
47. Nelson J. 1997. Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 101:355-358.
48. Nelson J, Crowhurst J, Carey B, Greed L. 2003. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet A 123A:310-313.
49. Neufeld EF, Muenzer J. 2001. The mucopolysaccharidoses. In: Scriver CR Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 8th edition. New York: McGraw-Hill Medical Publishing. pp 3421-3452.
50. Nicolini F, Corradi D, Bosio S, Gherli T. 2008. Aortic valve replacement in a patient with morquio syndrome. Heart Surg Forum 11:E96-E98.
51. Nursal TZ, Atli M, Kaynaroglu V. 2000. Morgagni hernia in a patient with Morquio syndrome. Hernia 4:37-39.
52. Olsen H, Baggesen K, Sjolie AK. 1993. Cataracts in Morquio syndrome (mucopolysaccharidosis IV A). Ophthalmic Paediatr Genet 14:87-89.
53. Pagel PS, Almassi GH. 2009. Perioperative implications of Morquio syndrome in a 31-year-old woman undergoing aortic valve replacement. J Cardiothorac Vasc Anesth 23:855-857.
54. Polman CH, Rudick RA. 2010. The multiple sclerosis functional composite: A clinically meaningful measure of disability. Neurology 74:S8-S15.
55. Poole JL, Burtner PA, Torres TA, McMullen CK, Markham A, Marcum ML, Anderson JB, Qualls C. 2005. Measuring dexterity in children using the Nine-hole Peg Test. J Hand Ther 18:348-351.
56. Pryce Lewis JR, Gibson PH. 2010. Bilateral hip replacement in three patients with lysosomal storage disease: Mucopolysaccharidosis type IV and mucolipidosis type III. J Bone Joint Surg Br 92:289-292.
57. Ransford AO, Crockard HA, Stevens JM, Modaghegh S. 1996. Occipito-atlanto-axial fusion in Morquio-Brailsford syndrome. A ten-year experience. J Bone Joint Surg Br 78:307-313.
58. Rekka P, Rathna PV, Jagadeesh S, Seshadri S. 2012. Mucopolysaccharidoses type IV A (Morquio syndrome): A case series of three siblings. J Indian Soc Pedod Prev Dent 30:66-69.
59. Riedner ED, Levin LS. 1977. Hearing patterns in Morquio's syndrome (mucopolysaccharidosis IV). Arch Otolaryngol 103:518-520.
60. Rølling I, Clausen N, Nyvad B, Sindet-Pedersen S. 1999. Dental findings in three siblings with Morquio's syndrome. Int J Paediatr Dent 9:219-224.
61. Shrikrishna D, Coker RK. 2011. Air travel working party of the British thoracic society standards of care committee. Managing passengers with stable respiratory disease planning air travel: British thoracic society recommendations. Thorax 66:831-833.
62. Solanki GA, Martin KW, Theroux MC, Lampe C, White KK, Shediac R, Lampe CG, Beck M, Mackenzie WG, Hendriksz CJ, Harmatz PR. 2013. Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): Presentation, diagnosis, and management. J Inherit Metab Dis 36:339-355.
63. Summers CG, Ashworth JL. 2011. Ocular manifestations as key features for diagnosing mucopolysaccharidoses. Rheumatology (Oxford) 50:v34-v40.
64. Tassinari E, Boriani L, Traina F, Dallari D, Toni A, Giunti A. 2008. Bilateral total hip arthroplasty in Morquio-Brailsford's syndrome: A report of two cases. Chir Organi Mov 92:123-126.
65. Theroux MC, Nerker T, Ditro C, Mackenzie WG. 2012. Anesthetic care and perioperative complications of children with Morquio syndrome. Paediatr Anaesth 22:901-907.
66. Tylki-Szymańska A, Czartoryska B, Bunge S, van Diggelen OP, Kleijer WJ, Poorthuis BJ, Huijmans JG, Górska D. 1998. Clinical, biochemical, and molecular findings in a two-generation Morquio A family. Clin Genet 53:369-374.
67. Tomatsu S, Montaño AM, Nishioka T, Gutierrez MA, Peña OM, Trandafirescu GG, Lopez P, Yamaguchi S, Noguchi A, Orii T. 2005. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 26:500-512.
68. Tomatsu S, Montaño AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, Dung VC, Nishioka T, Orii T, Sly WS. 2008. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet 17:815-824.
69. Tomatsu S, Montaño AM, Oikawa H, Rowan DJ, Smith M, Barrera L, Chinen Y, Thacker MM, Mackenzie WG, Suzuki Y, Orii T. 2011. Mucopolysaccharidosis type IVA (Morquio A disease): Clinical review and current treatment. Curr Pharm Biotechnol 12:931-945.
70. Walker R, Belani KG, Braunlin EA, Bruce IA, Hack H, Harmatz PR, Jones S, Rowe R, Solanki GA, Valdemarsson B. 2013. Anaesthesia and airway management in mucopolysaccharidosis. J Inherit Metab Dis 36:211-219.
71. White KK. 2012. Orthopaedic surgery for mucopolysaccharidosis. Curr Orthop Pract 23:394-399.
72. White KK, Jester A, Bache CE, Harmatz PR, Shediac R, Thacker MM, William G, Mackenzie WG. 2014. Orthopedic management of the extremities in patients with Morquio A syndrome. J Child Orthop 8:295-304.
73. Wood TC, Harvey K, Beck M, Burin MG, Chien YH, Church HJ, D'Almeida V, van Diggelen OP, Fietz M, Giugliani R, Harmatz P, Hawley SM, Hwu WL, Ketteridge D, Lukacs Z, Miller N, Pasquali M, Schenone A, Thompson JN, Tylee K, Yu C, Hendriksz CJ. 2013. Diagnosing mucopolysaccharidosis IVA. J Inherit Metab Dis 36:293-307.
74. Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF. 2004. Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human a-L-iduronidase (laronidase). J Pediatr 144:581-588.